Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference

Rhea-AI Summary

Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) announced its upcoming presentation at the Biotech Showcase Conference on January 10, 2023, at 9:00 AM PT in San Francisco, CA. The event will also feature one-on-one investor meetings from January 9 to 11. Attendees can view the live presentation and access recorded sessions on-demand. Comera focuses on transforming biologic medicines from intravenous to subcutaneous delivery, aiming for better patient autonomy and convenience. More information is available on their Investor Relations website.

WOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced that the company will present at the upcoming Biotech Showcase Conference on Tuesday, January 10, 2023 at 9:00 AM PT in San Francisco, CA.   

The Company will also host one-on-one meetings with investors from Monday, January 9 through Wednesday January 11.

This year, registered Biotech Showcase attendees can view the company presentation live. Also, attendees can view recorded presentations at their convenience with 24x7 on-demand access, when scheduling does not allow viewing during the main event week.

A live webcast of the presentation and a replay of the presentation will be available for 6 months under the “Events & Presentations” page in the Investor Relations section of the Company’s website at https://ir.comeralifesciences.com/news-events/events

About Comera Life Sciences

Leading a compassionate new era in medicine, Comera Life Sciences is applying a deep knowledge of formulation science and technology to transform essential biologic medicines from intravenous (IV) to subcutaneous (SQ) forms. The goal of this approach is to provide patients with the freedom of self-injectable care, reduce institutional dependency and to put patients at the center of their treatment regimen.

To learn more about the Comera Life Sciences mission, as well as the proprietary SQore™ platform, visit https://comeralifesciences.com/.

Contacts

Comera Investor
John Woolford
ICR Westwicke
John.Woolford@westwicke.com

Comera Press
Jon Yu
ICR Westwicke
ComeraPR@westwicke.com

FAQ

What is Comera Life Sciences presenting at the Biotech Showcase Conference?

Comera Life Sciences will present on January 10, 2023, at 9:00 AM PT.

When are the one-on-one investor meetings scheduled for Comera Life Sciences?

The one-on-one investor meetings are set from January 9 through January 11, 2023.

Where can I watch Comera Life Sciences' presentation?

The presentation can be viewed live at the Biotech Showcase Conference and will also be available for on-demand access for six months on their Investor Relations page.

What is the main goal of Comera Life Sciences as indicated in the press release?

Comera Life Sciences aims to transform biologic medicines from IV to subcutaneous forms to enhance patient self-care and accessibility.

What is the ticker symbol for Comera Life Sciences?

The ticker symbol for Comera Life Sciences is CMRA.